We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JXN:NYSEJackson Financial Inc. Analysis

Data as of 2026-04-12 - not real-time

$101.62

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Jackson Financial trades below its 20‑day and 50‑day simple moving averages, with the price hovering just above the 200‑day SMA, indicating a short‑term pullback within a longer‑term flat backdrop. The RSI sits in the low‑mid 40s and the MACD histogram has turned positive, giving a modest bullish signal despite decreasing volume and a neutral trend classification. Valuation metrics are strikingly cheap – forward P/E under 4 versus an industry average above 17, price‑to‑book below 1, and a dividend yield above 3% backed by a payout ratio under 50% and solid free cash flow. Fundamentally, the company posted double‑digit revenue growth in annuity sales, a strong cash position that matches its debt load, and a recent earnings turnaround highlighted in the news, while profitability remains thin.
The stock’s volatility is high (over 35% 30‑day) and beta exceeds 1.3, suggesting sensitivity to market swings, yet geographic exposure is limited to the United States, reducing currency concerns. Analyst consensus remains a “hold” with median price targets near $119, implying roughly 15‑20% upside from the current level. Overall, the blend of deep value multiples, improving earnings outlook, and a reliable dividend makes JXN a candidate for investors comfortable with medium‑term price recovery and willing to navigate short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term SMAs indicating near‑term weakness
  • Decreasing volume and neutral trend
  • Attractive dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervaluation relative to peers and forward earnings
  • Record annuity sales growth and improving earnings outlook
  • Sustainable dividend supported by strong cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable business model in life insurance and annuities
  • Consistent cash generation with manageable debt
  • Long‑term upside potential from valuation gap and sector tailwinds

Key Metrics & Analysis

Financial Health

Revenue Growth718.80%
Profit Margin0.40%
P/E Ratio3.9
ROE0.71%
ROA0.12%
Debt/Equity55.12
P/B Ratio0.7
Op. Cash Flow$5.8B
Free Cash Flow$1.7B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI42.3
Support$100.73
Resistance$109.60
MA 20$104.30
MA 50$110.09
MA 200$101.26
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$899.68
Target Price$122.00
Upside/Downside20.06%
GradeUndervalued
TypeBlend
Dividend Yield3.54%

Risk Assessment

Beta1.31
Volatility37.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.